MLL Gene Rearranged Acute Lymphoblastic Leukemia

被引：0
|
作者：
Pieters, Rob [1 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
MLL gene; Nucleoside; Stem cell transplantation; RAS mutations; Epigenetics; STEM-CELL TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; THERAPEUTIC TARGET; FLT3; EXPRESSION; INFANT; INHIBITION; CHEMOTHERAPY; INTERFANT-99; PROFILE; ABSENCE;
D O I：
10.1016/j.clml.2018.06.053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TH-S18-ALL
引用
收藏
页码：S48 / S50
页数：3
相关论文
共 50 条
  • [1] MLL-Rearranged Acute Lymphoblastic Leukemia
    Firas El Chaer
    Michael Keng
    Karen K. Ballen
    Current Hematologic Malignancy Reports, 2020, 15 : 83 - 89
  • [2] MLL-Rearranged Acute Lymphoblastic Leukemia
    El Chaer, Firas
    Keng, Michael
    Ballen, Karen K.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (02) : 83 - 89
  • [3] Unravelling the Mirnome of MLL-Rearranged Acute Lymphoblastic Leukemia
    Castro, Patricia Garrido
    Bueno, Clara
    van Roon, Eddy H. J.
    Pinhancos, Sandra S. Mimoso
    Schneider, Pauline
    Willekes, Merel
    Menendez, Pablo
    Pieters, Rob
    Stam, Ronald
    BLOOD, 2014, 124 (21)
  • [4] Targeting FLT3 in MLL gene rearranged infant Acute Lymphoblastic Leukemia (ALL).
    Stam, RW
    den Boer, ML
    Armstrong, SA
    Sallen, SE
    Kazemier, KM
    Pieters, R
    BLOOD, 2003, 102 (11) : 224A - 224A
  • [5] Epigenetic and Transcriptomic Profiling of MLL Rearranged Infant Acute Lymphoblastic Leukemia
    Isobe, Tomoya
    Sato, Aiko
    Yoshida, Kenichi
    Kobayashi, Chika
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Fukuda, Shiro
    Yamamoto, Shogo
    Tatsuno, Kenji
    Tsutsumi, Shuichi
    Kiyokawa, Nobutaka
    Aoki, Yuki
    Ishihara, Takashi
    Tomizawa, Daisuke
    Miyamura, Takako
    Ishii, Eiichi
    Miyano, Satoru
    Ogawa, Seishi
    Aburatani, Hiroyuki
    Mizutani, Shuki
    Takita, Junko
    Takagi, Masatoshi
    BLOOD, 2017, 130
  • [6] Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia
    R W Stam
    M L den Boer
    M M C J Passier
    G E Janka-Schaub
    S E Sallan
    S A Armstrong
    R Pieters
    Leukemia, 2006, 20 : 264 - 271
  • [7] Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia
    Stam, RW
    den Boer, ML
    Passier, MMCJ
    Janka-Schaub, GE
    Sallan, SE
    Armstrong, SA
    Pieters, R
    LEUKEMIA, 2006, 20 (02) : 264 - 271
  • [8] Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia
    Stam, RW
    den Boer, ML
    Schneider, P
    Nollau, P
    Horstmann, M
    Beverloo, HB
    van der Voort, E
    Valsecchi, MG
    de Lorenzo, P
    Sallan, SE
    Armstrong, SA
    Pieters, R
    BLOOD, 2005, 106 (07) : 2484 - 2490
  • [9] Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia
    Priscilla Wander
    Laurence C. Cheung
    Sandra S. Pinhanҫos
    Luke Jones
    Mark Kerstjens
    Susan T.C.J.M. Arentsen-Peters
    Sajla Singh
    Grace-Alyssa Chua
    Patricia Garrido Castro
    Pauline Schneider
    M. Emmy M. Dolman
    Bianca Koopmans
    Jan J. Molenaar
    Rob Pieters
    C. Michel Zwaan
    Rishi S. Kotecha
    Ronald W. Stam
    Leukemia, 2020, 34 : 2898 - 2902
  • [10] Distinct methylation patterns among infants with MLL rearranged acute lymphoblastic leukemia
    Stumpel, Dominique J. P. M.
    Schneider, Pauline
    Van Roon, Eddy H. J.
    Boer, Judith M.
    Menezes, Renee X.
    Pieters, Rob
    Stam, Ronald W.
    BLOOD, 2007, 110 (11) : 822A - 822A
12345